Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Rhodamine B Market by Application (Biotechnological, Industrial, Other Applications) and by End User (Textile Industries, Pharmaceutical Companies, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A03516

Pages: NA

Charts: NA

Tables: NA

Rhodamine B is a chemical compound that acts as a tracer dye, and assists to determine the rate as well as direction of flow and transport in water. The dyes consists of rhodamine B fluoresce, thus making the detection of the same becomes easy in fluorometers. Rhodamine B is essentially used to impart color in cotton and paper. The major factors that fuel the growth of the market are rise in demand for fluorescence dyes in biotechnological applications such as fluorescence microscopy, flow cytometry, and ELISA. In addition, large-scale utilization of staining techniques in various laboratory experiments supplements the market growth. However, side effects associated with utilization of rhodamine B, owing to its carcinogenic properties, restrain the growth of the market. Conversely, increase in R&D activities utilizing Rhodamine B such as rhodamine biomarkers is expected to offer profitable opportunities for the growth of the market.

The report segments the market on the basis of application, end user, and region. Based application, the market is divided into biotechnological, industrial, and other applications. Based on end user, the market is classified into textile industries, pharmaceutical companies, and others. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players profiled in this report are pharmaceutical companies Dharamchand & Co Private Limited, Huanghua Bohai Chemical Co. Ltd, Hebei Youhao Chemical Co., Ltd., Hangzhou Haiqiang Chemical Co., Ltd., Shenyang Jin Tianyuan Chemical Co., Ltd., Jhebei Youhao Yingwangtong, Shanghai Fuxin Fine Chemical Co., Ltd., Tianjin Zhongjin Pharmaceutical Co., Ltd., Dezhou Hongqiao Dyestuff Chemical Co., Ltd., and Qingdao ChuanLin Dye Industry Co., Ltd.

Key Benefits

  • The study provides an in-depth analysis of the global Rhodamine B market with current trends and future estimations to elucidate the imminent investment pockets.
  • It presents a quantitative analysis to enable the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis of the market by type assists to understand the various forms of Rhodamine B available.
  • Key players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of the market.

Key Market Segments

  • By Application
    • Biotechnological
    • Industrial
    • Other Applications
  • By End User
    • Textile Industries
    • Pharmaceutical Companies
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA


Key Market Players

  • Tianjin Zhongjin Pharmaceutical Co.Ltd.
  • Shenyang Jin Tianyuan Chemical Co. Ltd.
  • Hebei Youhao Chemical Co. Ltd.
  • Huanghua Bohai Chemical Co. Ltd
  • Hangzhou Haiqiang Chemical Co.Ltd.
  • Qingdao ChuanLin Dye Industry Co. Ltd.
  • Dharamchand & Co Private Limited
  • Dezhou Hongqiao Dyestuff Chemical Co. Ltd.
  • Shanghai Fuxin Fine Chemical Co. Ltd.
  • Jhebei Youhao Yingwangtong
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: RHODAMINE B MARKET, BY APPLICATION

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Application

    • 4.2. Biotechnological

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Industrial

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Other Applications

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: RHODAMINE B MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Textile Industries

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Pharmaceutical Companies

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Others

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: RHODAMINE B MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Application

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Rhodamine B Market

        • 6.2.5.1. Market Size and Forecast, By Application
        • 6.2.5.2. Market Size and Forecast, By End User
      • 6.2.6. Canada Rhodamine B Market

        • 6.2.6.1. Market Size and Forecast, By Application
        • 6.2.6.2. Market Size and Forecast, By End User
      • 6.2.7. Mexico Rhodamine B Market

        • 6.2.7.1. Market Size and Forecast, By Application
        • 6.2.7.2. Market Size and Forecast, By End User
    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Application

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Rhodamine B Market

        • 6.3.5.1. Market Size and Forecast, By Application
        • 6.3.5.2. Market Size and Forecast, By End User
      • 6.3.6. Germany Rhodamine B Market

        • 6.3.6.1. Market Size and Forecast, By Application
        • 6.3.6.2. Market Size and Forecast, By End User
      • 6.3.7. Italy Rhodamine B Market

        • 6.3.7.1. Market Size and Forecast, By Application
        • 6.3.7.2. Market Size and Forecast, By End User
      • 6.3.8. Spain Rhodamine B Market

        • 6.3.8.1. Market Size and Forecast, By Application
        • 6.3.8.2. Market Size and Forecast, By End User
      • 6.3.9. UK Rhodamine B Market

        • 6.3.9.1. Market Size and Forecast, By Application
        • 6.3.9.2. Market Size and Forecast, By End User
      • 6.3.10. Russia Rhodamine B Market

        • 6.3.10.1. Market Size and Forecast, By Application
        • 6.3.10.2. Market Size and Forecast, By End User
      • 6.3.11. Rest Of Europe Rhodamine B Market

        • 6.3.11.1. Market Size and Forecast, By Application
        • 6.3.11.2. Market Size and Forecast, By End User
    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Application

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Rhodamine B Market

        • 6.4.5.1. Market Size and Forecast, By Application
        • 6.4.5.2. Market Size and Forecast, By End User
      • 6.4.6. Japan Rhodamine B Market

        • 6.4.6.1. Market Size and Forecast, By Application
        • 6.4.6.2. Market Size and Forecast, By End User
      • 6.4.7. India Rhodamine B Market

        • 6.4.7.1. Market Size and Forecast, By Application
        • 6.4.7.2. Market Size and Forecast, By End User
      • 6.4.8. South Korea Rhodamine B Market

        • 6.4.8.1. Market Size and Forecast, By Application
        • 6.4.8.2. Market Size and Forecast, By End User
      • 6.4.9. Australia Rhodamine B Market

        • 6.4.9.1. Market Size and Forecast, By Application
        • 6.4.9.2. Market Size and Forecast, By End User
      • 6.4.10. Thailand Rhodamine B Market

        • 6.4.10.1. Market Size and Forecast, By Application
        • 6.4.10.2. Market Size and Forecast, By End User
      • 6.4.11. Malaysia Rhodamine B Market

        • 6.4.11.1. Market Size and Forecast, By Application
        • 6.4.11.2. Market Size and Forecast, By End User
      • 6.4.12. Indonesia Rhodamine B Market

        • 6.4.12.1. Market Size and Forecast, By Application
        • 6.4.12.2. Market Size and Forecast, By End User
      • 6.4.13. Rest of Asia Pacific Rhodamine B Market

        • 6.4.13.1. Market Size and Forecast, By Application
        • 6.4.13.2. Market Size and Forecast, By End User
    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Application

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Rhodamine B Market

        • 6.5.5.1. Market Size and Forecast, By Application
        • 6.5.5.2. Market Size and Forecast, By End User
      • 6.5.6. South Africa Rhodamine B Market

        • 6.5.6.1. Market Size and Forecast, By Application
        • 6.5.6.2. Market Size and Forecast, By End User
      • 6.5.7. Saudi Arabia Rhodamine B Market

        • 6.5.7.1. Market Size and Forecast, By Application
        • 6.5.7.2. Market Size and Forecast, By End User
      • 6.5.8. UAE Rhodamine B Market

        • 6.5.8.1. Market Size and Forecast, By Application
        • 6.5.8.2. Market Size and Forecast, By End User
      • 6.5.9. Argentina Rhodamine B Market

        • 6.5.9.1. Market Size and Forecast, By Application
        • 6.5.9.2. Market Size and Forecast, By End User
      • 6.5.10. Rest of LAMEA Rhodamine B Market

        • 6.5.10.1. Market Size and Forecast, By Application
        • 6.5.10.2. Market Size and Forecast, By End User
  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Dharamchand And Co Private Limited

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Huanghua Bohai Chemical Co. Ltd

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Hebei Youhao Chemical Co. Ltd.

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Hangzhou Haiqiang Chemical Co.Ltd.

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Shenyang Jin Tianyuan Chemical Co. Ltd.

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Jhebei Youhao Yingwangtong

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Shanghai Fuxin Fine Chemical Co. Ltd.

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Tianjin Zhongjin Pharmaceutical Co.Ltd.

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Dezhou Hongqiao Dyestuff Chemical Co. Ltd.

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Qingdao ChuanLin Dye Industry Co. Ltd.

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL RHODAMINE B MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL RHODAMINE B MARKET FOR BIOTECHNOLOGICAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL RHODAMINE B MARKET FOR INDUSTRIAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL RHODAMINE B MARKET FOR OTHER APPLICATIONS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL RHODAMINE B MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL RHODAMINE B MARKET FOR TEXTILE INDUSTRIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL RHODAMINE B MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL RHODAMINE B MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL RHODAMINE B MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. NORTH AMERICA RHODAMINE B, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. NORTH AMERICA RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 12. NORTH AMERICA RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 13. U.S. RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 14. U.S. RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 15. CANADA RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 16. CANADA RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 17. MEXICO RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 18. MEXICO RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 19. EUROPE RHODAMINE B, BY REGION, 2025-2033 ($MILLION)
  • TABLE 20. EUROPE RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 21. EUROPE RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 22. FRANCE RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 23. FRANCE RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 24. GERMANY RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 25. GERMANY RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 26. ITALY RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 27. ITALY RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 28. SPAIN RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 29. SPAIN RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 30. UK RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 31. UK RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 32. RUSSIA RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 33. RUSSIA RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 34. REST OF EUROPE RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 35. REST OF EUROPE RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 36. ASIA-PACIFIC RHODAMINE B, BY REGION, 2025-2033 ($MILLION)
  • TABLE 37. ASIA-PACIFIC RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 38. ASIA-PACIFIC RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 39. CHINA RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 40. CHINA RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 41. JAPAN RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 42. JAPAN RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 43. INDIA RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 44. INDIA RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 45. SOUTH KOREA RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 46. SOUTH KOREA RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 47. AUSTRALIA RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 48. AUSTRALIA RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 49. THAILAND RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 50. THAILAND RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 51. MALAYSIA RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 52. MALAYSIA RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 53. INDONESIA RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 54. INDONESIA RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 55. REST OF ASIA PACIFIC RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 56. REST OF ASIA PACIFIC RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 57. LAMEA RHODAMINE B, BY REGION, 2025-2033 ($MILLION)
  • TABLE 58. LAMEA RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 59. LAMEA RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 60. BRAZIL RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 61. BRAZIL RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 62. SOUTH AFRICA RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 63. SOUTH AFRICA RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 64. SAUDI ARABIA RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 65. SAUDI ARABIA RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 66. UAE RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 67. UAE RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 68. ARGENTINA RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 69. ARGENTINA RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 70. REST OF LAMEA RHODAMINE B, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 71. REST OF LAMEA RHODAMINE B, BY END USER, 2025-2033 ($MILLION)
  • TABLE 72. DHARAMCHAND AND CO PRIVATE LIMITED: KEY EXECUTIVES
  • TABLE 73. DHARAMCHAND AND CO PRIVATE LIMITED: COMPANY SNAPSHOT
  • TABLE 74. DHARAMCHAND AND CO PRIVATE LIMITED: OPERATING SEGMENTS
  • TABLE 75. DHARAMCHAND AND CO PRIVATE LIMITED: PRODUCT PORTFOLIO
  • TABLE 76. DHARAMCHAND AND CO PRIVATE LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 77. HUANGHUA BOHAI CHEMICAL CO. LTD: KEY EXECUTIVES
  • TABLE 78. HUANGHUA BOHAI CHEMICAL CO. LTD: COMPANY SNAPSHOT
  • TABLE 79. HUANGHUA BOHAI CHEMICAL CO. LTD: OPERATING SEGMENTS
  • TABLE 80. HUANGHUA BOHAI CHEMICAL CO. LTD: PRODUCT PORTFOLIO
  • TABLE 81. HUANGHUA BOHAI CHEMICAL CO. LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 82. HEBEI YOUHAO CHEMICAL CO. LTD.: KEY EXECUTIVES
  • TABLE 83. HEBEI YOUHAO CHEMICAL CO. LTD.: COMPANY SNAPSHOT
  • TABLE 84. HEBEI YOUHAO CHEMICAL CO. LTD.: OPERATING SEGMENTS
  • TABLE 85. HEBEI YOUHAO CHEMICAL CO. LTD.: PRODUCT PORTFOLIO
  • TABLE 86. HEBEI YOUHAO CHEMICAL CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 87. HANGZHOU HAIQIANG CHEMICAL CO.LTD.: KEY EXECUTIVES
  • TABLE 88. HANGZHOU HAIQIANG CHEMICAL CO.LTD.: COMPANY SNAPSHOT
  • TABLE 89. HANGZHOU HAIQIANG CHEMICAL CO.LTD.: OPERATING SEGMENTS
  • TABLE 90. HANGZHOU HAIQIANG CHEMICAL CO.LTD.: PRODUCT PORTFOLIO
  • TABLE 91. HANGZHOU HAIQIANG CHEMICAL CO.LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 92. SHENYANG JIN TIANYUAN CHEMICAL CO. LTD.: KEY EXECUTIVES
  • TABLE 93. SHENYANG JIN TIANYUAN CHEMICAL CO. LTD.: COMPANY SNAPSHOT
  • TABLE 94. SHENYANG JIN TIANYUAN CHEMICAL CO. LTD.: OPERATING SEGMENTS
  • TABLE 95. SHENYANG JIN TIANYUAN CHEMICAL CO. LTD.: PRODUCT PORTFOLIO
  • TABLE 96. SHENYANG JIN TIANYUAN CHEMICAL CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 97. JHEBEI YOUHAO YINGWANGTONG: KEY EXECUTIVES
  • TABLE 98. JHEBEI YOUHAO YINGWANGTONG: COMPANY SNAPSHOT
  • TABLE 99. JHEBEI YOUHAO YINGWANGTONG: OPERATING SEGMENTS
  • TABLE 100. JHEBEI YOUHAO YINGWANGTONG: PRODUCT PORTFOLIO
  • TABLE 101. JHEBEI YOUHAO YINGWANGTONG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 102. SHANGHAI FUXIN FINE CHEMICAL CO. LTD.: KEY EXECUTIVES
  • TABLE 103. SHANGHAI FUXIN FINE CHEMICAL CO. LTD.: COMPANY SNAPSHOT
  • TABLE 104. SHANGHAI FUXIN FINE CHEMICAL CO. LTD.: OPERATING SEGMENTS
  • TABLE 105. SHANGHAI FUXIN FINE CHEMICAL CO. LTD.: PRODUCT PORTFOLIO
  • TABLE 106. SHANGHAI FUXIN FINE CHEMICAL CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 107. TIANJIN ZHONGJIN PHARMACEUTICAL CO.LTD.: KEY EXECUTIVES
  • TABLE 108. TIANJIN ZHONGJIN PHARMACEUTICAL CO.LTD.: COMPANY SNAPSHOT
  • TABLE 109. TIANJIN ZHONGJIN PHARMACEUTICAL CO.LTD.: OPERATING SEGMENTS
  • TABLE 110. TIANJIN ZHONGJIN PHARMACEUTICAL CO.LTD.: PRODUCT PORTFOLIO
  • TABLE 111. TIANJIN ZHONGJIN PHARMACEUTICAL CO.LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. DEZHOU HONGQIAO DYESTUFF CHEMICAL CO. LTD.: KEY EXECUTIVES
  • TABLE 113. DEZHOU HONGQIAO DYESTUFF CHEMICAL CO. LTD.: COMPANY SNAPSHOT
  • TABLE 114. DEZHOU HONGQIAO DYESTUFF CHEMICAL CO. LTD.: OPERATING SEGMENTS
  • TABLE 115. DEZHOU HONGQIAO DYESTUFF CHEMICAL CO. LTD.: PRODUCT PORTFOLIO
  • TABLE 116. DEZHOU HONGQIAO DYESTUFF CHEMICAL CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. QINGDAO CHUANLIN DYE INDUSTRY CO. LTD.: KEY EXECUTIVES
  • TABLE 118. QINGDAO CHUANLIN DYE INDUSTRY CO. LTD.: COMPANY SNAPSHOT
  • TABLE 119. QINGDAO CHUANLIN DYE INDUSTRY CO. LTD.: OPERATING SEGMENTS
  • TABLE 120. QINGDAO CHUANLIN DYE INDUSTRY CO. LTD.: PRODUCT PORTFOLIO
  • TABLE 121. QINGDAO CHUANLIN DYE INDUSTRY CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL RHODAMINE B MARKET SEGMENTATION
  • FIGURE 2. GLOBAL RHODAMINE B MARKET
  • FIGURE 3. SEGMENTATION RHODAMINE B MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN RHODAMINE B MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALRHODAMINE B MARKET
  • FIGURE 11. RHODAMINE B MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 12. RHODAMINE B MARKET FOR BIOTECHNOLOGICAL, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. RHODAMINE B MARKET FOR INDUSTRIAL, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. RHODAMINE B MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. RHODAMINE B MARKET SEGMENTATION, BY BY END USER
  • FIGURE 16. RHODAMINE B MARKET FOR TEXTILE INDUSTRIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. RHODAMINE B MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. RHODAMINE B MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 20. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 21. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 22. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 23. COMPETITIVE DASHBOARD
  • FIGURE 24. COMPETITIVE HEATMAP: RHODAMINE B MARKET
  • FIGURE 25. TOP PLAYER POSITIONING, 2024
  • FIGURE 26. DHARAMCHAND AND CO PRIVATE LIMITED: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 27. DHARAMCHAND AND CO PRIVATE LIMITED: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 28. DHARAMCHAND AND CO PRIVATE LIMITED: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 29. HUANGHUA BOHAI CHEMICAL CO. LTD: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 30. HUANGHUA BOHAI CHEMICAL CO. LTD: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 31. HUANGHUA BOHAI CHEMICAL CO. LTD: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 32. HEBEI YOUHAO CHEMICAL CO. LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 33. HEBEI YOUHAO CHEMICAL CO. LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 34. HEBEI YOUHAO CHEMICAL CO. LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 35. HANGZHOU HAIQIANG CHEMICAL CO.LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. HANGZHOU HAIQIANG CHEMICAL CO.LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. HANGZHOU HAIQIANG CHEMICAL CO.LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. SHENYANG JIN TIANYUAN CHEMICAL CO. LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. SHENYANG JIN TIANYUAN CHEMICAL CO. LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. SHENYANG JIN TIANYUAN CHEMICAL CO. LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. JHEBEI YOUHAO YINGWANGTONG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. JHEBEI YOUHAO YINGWANGTONG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. JHEBEI YOUHAO YINGWANGTONG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. SHANGHAI FUXIN FINE CHEMICAL CO. LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. SHANGHAI FUXIN FINE CHEMICAL CO. LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. SHANGHAI FUXIN FINE CHEMICAL CO. LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. TIANJIN ZHONGJIN PHARMACEUTICAL CO.LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. TIANJIN ZHONGJIN PHARMACEUTICAL CO.LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. TIANJIN ZHONGJIN PHARMACEUTICAL CO.LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. DEZHOU HONGQIAO DYESTUFF CHEMICAL CO. LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. DEZHOU HONGQIAO DYESTUFF CHEMICAL CO. LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. DEZHOU HONGQIAO DYESTUFF CHEMICAL CO. LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. QINGDAO CHUANLIN DYE INDUSTRY CO. LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. QINGDAO CHUANLIN DYE INDUSTRY CO. LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. QINGDAO CHUANLIN DYE INDUSTRY CO. LTD.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Rhodamine B Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue